# Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis

> **NCT00762346** · PHASE4 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 156 (actual)

## Conditions studied

- Non Small Cell Lung Cancer
- Bone Metastases
- High NTX Level

## Interventions

- **DRUG:** zometa

## Key facts

- **NCT ID:** NCT00762346
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2013-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00762346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00762346, "Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00762346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*